Product Description: Antitumor agent-155 (Compound 13) inhibits microtubule polymerization, induces autophagy and apoptosis. Antitumor agent-155 shows cytotoxicity against HCT116, A549, AGS, SK-MES-1 cells with IC50s of 0.227, 0.253, 0.574, 0.423 μM respectively[1].
Formula: C30H34N2O6
References: [1]Zhang H, et al. Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells. Eur J Med Chem. 2024 Jun 5;272:116497.
Molecular Weight: 518.60
Research Area: Cancer
Target: Apoptosis;Autophagy;Microtubule/Tubulin